The interaction of GBMs with autophagy signaling pathways could affect key autophagy-regulating proteins, such as Beclin-1, LC3, mTOR, and AMPK (AMP-activated protein kinase), either enhancing or suppressing autophagy; thus, modulating the survival or death of cancer cells. This evidence concerns the gene MAP1LC3A and cancer.